Men and women can respond differently to GLP-1 medications
BCKAs, branched-chain ketoacids
Six medications are now authorized by Health Canada for long-term weight management: liraglutide (Saxenda), naltrexone/bupropion (Contrave), orlistat (Xenical), semaglutide (Wegovy), tirzepatide (Zepbound), and setmelanotide (Imcivree)
Reuters reports that generic semaglutide in India is expected to come at discounts of 5060%, with monthly prices for the lowest dose potentially falling from about 11,000 to 3,0005,000 as early generics arrive, and eventually to around 1,5002,500
1 2 A widely cited 2018 analysis by Pickart and Margolina examined GHKs influence on gene expression and reported that the peptide modulates a strikingly large number of human genes with enrichment in pathways governing tissue remodeling, antioxidant response, and DNA repair
Free Radic Res 21 : 267276